ויטמין A ואוסטיאופורוזיס
דיון מתוך פורום בעיות הורמונליות ומחלות עצם מטבוליות - אוסטיאופורוזיס
ד"ר איש-שלום הנכבדה, מטופלים שונים הלוקים באוסטיאופורוזיס נוטלים במקביל ומסיבות שונות גם תכשירים המכילים צורות שונות של ויטמין A כחלק ממולטי-ויטמינים או, לדוגמא, כטיפות המכילות ויטמין A+D שמשמשות בדר"כ לטיפול בפעוטות. יש חולים באוסטיאופורוזיס שבשלב מסוים בטיפול "נתקעים" ולא משתפרים יותר ואתה תוהה, בינך לבין עצמך, מה הסיבה.ויטמין A, כנראה, לא כל כך ידידותי לבניית העצם (אני מקווה שלמרות שההגדרה לא כל כך מקצועית היא מובנת). מתחייבת, כמובן, השאלה האם לנוכחות ויטמין A בכמות גדולה מהרצוי לנושא זה עשויה להיות הסבר לתופעה אותה תיארתי ואם כן כיצד לבחור למטופל את המולטי-ויטמין המתאים לו, מבחינה של תכולה של ויטמין A. האם, בנוסף, יש גם הבדל בין הצורות השונות של ויטמין A מבחינת השפעתם זאת ? שנה טובה וגמר חתימה טובה.
לרופא שלום רב, ויטמין A במינון עודף אכן עלול להגדיל סיכון לשברים. מצורף מאמר סקירה בנושא. ברמה העקרונית אין כמעט מולטיויטמינים שמכילים פחות מ- 3000 מקג' רטינול אשר עלול להגביר סיכון שברים. בטא קרוטן אינו קשור בהגברת סיכון שברים. אני אישית מעדיפה למלא את החסרים על ידי ויטמינים ספציפיים ולא על ידי מולטיויטמינים. לגבי העובדה שהחולים נתקעים, אתה בודאי מתכוון לצפיפות העצם, שאינה עולה עוד. אין לצפות לעליה בצפיפות העצם לאורך זמן תוך טיפול בתרופות נוגדות פרוק, המקובלות היום לטיפול באוסטאופורוזיס, גם ללא צריכה מוגברת של ויטמין A. Vitamin A and Hip Fracture: Should We be Concerned? Katherine L Tucker January 2002 Until quite recently, the focus of nutrition research and policy has been on preventing deficiency. Both in the US and elsewhere, tremendous progress against nutrient deficiencies has been made through the enrichment and fortification of foods. Far less attention has been given to the possible negative effects of high intakes of vitamins or minerals. In a recent issue of the Journal of the American Medical Association, Feskanich and colleagues showed that relatively high usual intake of vitamin A, as retinol, was associated with increased risk of hip fracture (1). Among more than 70,000 postmenopausal women participating in the Nurses Health Study, those with vitamin A intakes greater than 3000 g of retinol equivalents per day were 1.5 times more likely to suffer a hip fracture during 18 years of follow-up than were those consuming less than 1250 g (p for trend .01). More specifically, those consuming more than 2000 vs. 500 g of retinol were 1.9 times more likely to have a hip fracture (p .001). A similar, though less significant, association remained for the subset of non-supplement users who consumed greater than 1000 vs 400 g of retinol from food (OR=1.7). No association was seen with intake of beta-carotene, the precurser of vitamin A found largely in fruits and vegetables. The recent report on dietary reference intakes, from the Institute of Medicine (IOM), set the new RDA for vitamin A at 900 g for men and 700 g for women, with an upper limit of 3000 g per day of preformed vitamin A (2). The committee based this upper limit on evidence of teratogenicity with high vitamin A intakes. Although they reviewed existing evidence on vitamin A and bone status, they concluded that existing studies showed conflicting results and were, therefore, not useful in setting an upper limit. The Feskanich et al. study was not available during the deliberations of the IOM committee. It supports the findings of another recent study (3) that found that vitamin A intakes above 1500 mg were significantly associated with both lower bone mineral density and greater risk of hip fracture in Swedish women. On the other hand, three studies of US women (4-6) did not find associations between vitamin A intake and bone status and/or fracture. Furthermore, a recent cross sectional analysis of the Third National Health and Nutrition Examination Survey (NHANES III) found no association between serum retinyl esters and bone mineral density at the femoral neck, trochanter, intertrochanter, or total hip in 5790 adults (7). The Feskanich study has several advantages. First, it is the largest study available on this topic to date, with 603 incident hip fractures from low-moderate trauma among more than 70,000 women. Multiple dietary assessments improved estimation of long term exposure prior to fracture. Although no dietary assessment is without error, the use of food frequency questionnaire is particularly appropriate for vitamin A, given the large day-to-day variability in intake associated with few concentrated food sources. However, observational studies cannot prove causality. Incomplete control of confounding is of particular concern in studies of nutrient intake, due to collinearity of nutrients in the diet and to their interactive effects. Feskanich et al. included intake of calcium, vitamin D, vitamin K, protein, alcohol and caffeine in their models of vitamin A and fracture. However, the shape of the associations of several nutrients on bone status and hip fracture remain inconclusive and adjustment is, therefore, likely to be imperfect. Some, including alcohol and protein, appear to have negative effects on bone at both the lower and upper end of their intake distributions. Nutrient supplements are also problematic as most subjects take multivitamin preparations from which the retinol cannot easily be separated from other nutrients in the same preparation. It is a strength of this study that relatively consistent results were seen for retinol from food + supplements and from food alone. The strength of the association was moderate, and appeared variable for many of the sub-analyses, but was greatest (OR=2.5 (1.5-4.3)) among non-postmenopausal hormone users with retinol intakes 2000 relative to 500 g. In contrast, associations were not significant among hormone users, suggesting a protective effect of hormones in the face of high retinol intake. This interaction is an important finding and raises questions about the mechanism of protection by hormone use. Numerous animal and in vitro studies support the biological plausibility of a causal link between retinol and bone, as recently reviewed by Binkley and Krueger (8). In several animal species, high retinol has been shown to stimulate bone resorption and to inhibit bone formation. It has also been shown to antagonize the action of vitamin D in rats (9). A limitation of the study by Feskanich et al. was the absence of biological markers, such as serum retinol or bone mineral density measures to support the association between intake and fracture. The lack of consistency in the existing literature, including the finding of no association between elevated serum retinyl esters and low bone mineral density in the NHANES III (10) suggests that further research is needed. In the meantime, the suggestion by this well conducted longitudinal study that intakes as low as 2000 g of retinol--an amount consumed by a large segment of the population--may be associated with increased risk of fracture is important. These intake levels are well below the recently set upper limit of 3000 g per day of preformed vitamin A and raise concern regarding levels of food fortification and the use of retinol supplements by US adults. Indeed, with more and more fortified foods on the market and larger segments of the population using nutrient supplements, considerably more attention to the risks of high nutrient intakes should become a priority. References 1. Feskanich D, Singh V, Willett WC, Colditz GA. Vitamin A intake and hip fractures among postmenopausal women. JAMA. 2002 Jan 2;287(1):47-54. [Abstract] 2. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Institute of Medicine. 2001. National Academy Press, Washington, D.C. 3. Melhus H, Michaelsson K, Kindmark A, Bergstrom R, Holmberg L, Mallmin H, Wolk A, Ljunghall S. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med. 1998 Nov 15;129(10):770-8. [Abstract] 4. Freudenheim JL, Johnson NE, Smith EL. Relationships between usual nutrient intake and bone-mineral content of women 35-65 years of age: longitudinal and cross-sectional analysis. Am J Clin Nutr. 1986 Dec;44(6):863-76. [Abstract] 5. Sowers MF, Wallace RB. Retinol, supplemental vitamin A and bone status. J Clin Epidemiol. 1990;43(7):693-9. [Abstract] 6. Houtkooper LB, Ritenbaugh C, Aickin M, Lohman TG, Going SB, Weber JL, Greaves KA, Boyden TW, Pamenter RW, Hall MC. Nutrients, body composition and exercise are related to change in bone mineral density in premenopausal women. J Nutr. 1995 May;125(5):1229-37. [Abstract] 7. Ballew C, Galuska D, Gillespie C. High serum retinyl esters are not associated with reduced bone mineral density in the Third National Health And Nutrition Examination Survey, 1988-1994. J Bone Miner Res. 2001 Dec;16(12):2306-12. [Abstract] 8. Binkley N, Krueger D. Hypervitaminosis A and bone. Nutr Rev. 2000 May;58(5):138-44. [Abstract] 9. Rohde CM, Manatt M, Clagett-Dame M, DeLuca HF. Vitamin A antagonizes the action of vitamin D in rats. J Nutr. 1999 Dec;129(12):2246-50. [Abstract][Full Text] 10. Ballew C, Bowman BA, Sowell AL, Gillespie C. Serum retinol distributions in residents of the United States: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2001 Mar;73(3):586-93. [Abstract] בברכת שנה טובה ד"ר צופיה איש-שלום
שלום לד"ר איש שלום, ראשית - תודה. שנית - הזדמנות להודות על ניהול הפורום ברמה הראויה לחיקוי ואשר גם הצד האנושי לא יוצא בה נפסד. שוב, שנה טובה וגמר חתימה טובה